Abstract

Cardiac alternans have crucial importance in the onset of ventricular fibrillation. The early explanation for alternans development was the voltage-driven mechanism, where the action potential (AP) restitution steepness was considered as crucial determining factor. Recent results suggest that restitution slope is an inadequate predictor for alternans development, but several studies still claim the role of membrane potential as underlying mechanism of alternans. These controversial data indicate that the relationship of restitution and alternans development is not completely understood. APs were measured by conventional microelectrode technique from canine right ventricular papillary muscles. Ionic currents combined with fluorescent measurements were recorded by patch-clamp technique. APs combined with fluorescent measurements were monitored by sharp microelectrodes. Rapid pacing evoked restitution-independent AP duration (APD) alternans. When non-alternating AP voltage command was used, Ca2+i-transient (CaT) alternans were not observed. When alternating rectangular voltage pulses were applied, CaT alternans were proportional to ICaL amplitude alternans. Selective ICaL inhibition did not influence the fast phase of APD restitution. In this study we found that ICaL has minor contribution in shaping the fast phase of restitution curve suggesting that ICaL—if it plays important role in the alternans mechanism—could be an additional factor that attenuates the reliability of APD restitution slope to predict alternans.

Details

Title
The development of L-type Ca2+ current mediated alternans does not depend on the restitution slope in canine ventricular myocardium
Author
Tóth Noémi 1 ; Szlovák Jozefina 1 ; Kohajda Zsófia 2 ; Bitay Gergő 1 ; Veress, Roland 3 ; Horváth Balázs 4 ; Papp Julius Gy 5 ; Varró András 6 ; Nagy, Norbert 5 

 University of Szeged, Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Szeged, Hungary (GRID:grid.9008.1) (ISNI:0000 0001 1016 9625) 
 ELKH-SZTE Research Group of Cardiovascular Pharmacology, Szeged, Hungary (GRID:grid.9008.1) 
 University of Debrecen, Department of Physiology, Faculty of Medicine, Debrecen, Hungary (GRID:grid.7122.6) (ISNI:0000 0001 1088 8582) 
 University of Debrecen, Department of Physiology, Faculty of Medicine, Debrecen, Hungary (GRID:grid.7122.6) (ISNI:0000 0001 1088 8582); University of Debrecen, Faculty of Pharmacy, Debrecen, Hungary (GRID:grid.7122.6) (ISNI:0000 0001 1088 8582) 
 University of Szeged, Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Szeged, Hungary (GRID:grid.9008.1) (ISNI:0000 0001 1016 9625); ELKH-SZTE Research Group of Cardiovascular Pharmacology, Szeged, Hungary (GRID:grid.9008.1) 
 University of Szeged, Department of Pharmacology and Pharmacotherapy, Faculty of Medicine, Szeged, Hungary (GRID:grid.9008.1) (ISNI:0000 0001 1016 9625); ELKH-SZTE Research Group of Cardiovascular Pharmacology, Szeged, Hungary (GRID:grid.9008.1); University of Szeged, Department of Pharmacology and Pharmacotherapy, Interdisciplinary Excellence Centre, Szeged, Hungary (GRID:grid.9008.1) (ISNI:0000 0001 1016 9625) 
Publication year
2021
Publication date
2021
Publisher
Nature Publishing Group
e-ISSN
20452322
Source type
Scholarly Journal
Language of publication
English
ProQuest document ID
2562073193
Copyright
© The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License.